----

----

• Exploration – Hypothesis Development Award (EHDA)
• Early Investigator Research Award (EIRA)
• Physician Research Award (PRA)
• Translational Science Award (TSA)
• Health Disparity Research Award (HDRA)
• Idea Development Award (IDA)
• Data Science Award (DSA)

Program Announcement/Instructions

• Concept Award (CA)
• Idea Development Award (IDA)
• Postdoctoral and Clinical Fellowship Award (PCFA)
• Translational Research Partnership Award (TRPA)

Program Announcement/Instructions

• Behavioral Health Science Award (BHSA)
• Career Development Award (CDA) – Fellow Option
• Career Development Award (CDA) – Virtual Cancer Center Scholar Option
• Translational Team Science Award (TTSA)
• Convergent Science Cancer Consortium Development Award (CSCCDA)
• Idea Award (IA)
• Impact Award (IPA)

Program Announcement/Instructions

• Concept Award (CA)
• Idea Development Award (IDA)
• Resource and Community Development Award (RCDA)

Program Announcement/Instructions

• Career Development Award (CDA)
• Concept Award (CA)
• Clinical Translational Research Partnership Award (CTRPA)
• Idea Development Award (IDA)
• Investigator-Initiated Translational Research Award (IITRA)

Program Announcement/Instructions

Program Overview

The Stanford Cancer Center Clinical Innovation Fund (CIF) seeks to drive, and fund innovative projects designed to elevate the quality of care, enhance the patient/provider experience, and expand Stanford Cancer Center outreach & growth, as aligned with Stanford Cancer Transformation.

CIF accepts proposal submissions twice a year on: January 31st and July 31^st

Proposals should be designed to:

• Enhance the patient & provider experience
• Improve quality of care in outpatient/inpatient settings
• Promote clinical outreach and Cancer Center volume growth
• Increase value of care by reducing costs while improving patient care
• Promote physician, nursing, and APP education around cancer and overall care delivery
•  
• When preparing your proposal for submission, it is important to keep the following items in mind:
• Eligibility is open to Cancer Service Line (CSL) providers (MD & APP), nursing staff (coordinators, clinical), and administrators/managers. Non-CSL affiliated personnel who are interested in submitting a CIF proposal must align their project with a CSL member or affiliate as an active PI or Co-PI for the proposal to be considered for funding.
• Total project budget for the proposal cannot exceed $150,000. 
• Total project salaries for faculty physicians and benefits cannot exceed 10% of the total budget requested.
• Supplemental information is encouraged any format (.doc, .ppt , .pdf, .jpeg, .mp4, .wav, etc.). Additional supplements can be added to an application that has already been submitted, provided the materials are received before 11:59pm PT on the date of the deadline.

• All proposals should be submitted on the CIF Application form via email to the Clinical Innovation Fund.  Directions on how to complete the application can be found here. After a submission cycle closes, each proposal undergoes several rounds of review to ensure Cancer Transformation goals alignment, innovative potential, and feasibility. Requestors can expect to receive a decision response approximately two months after the funding deadlines.

• Extension Requests:
• PIs with CIF awarded projects can request for an extension with the following in mind:
• Complete this form to request for an extension and submit to the Clinical Innovation Fund.
• Requests should be submitted two months before the project end date to provide CIF leadership time to review.
• Requests for extensions submitted after project end date will be at risk of losing access to any remaining funds in budget. 
• Extensions can be requested for up to 1 additional year.

• Forms
• CIF application
• Directions on how to complete the application
• Request for Extension
• Request for Change in Budget

On October 30, 2017 the National Cancer Institute is pleased to announce the release of 17 new Cancer Moonshot funding opportunities. As you know, efforts supported through the Cancer Moonshot aim to accelerate cancer research, making more therapies available to patients and improving the ability to prevent cancer and detect it the earliest stage possible.

Following receipt of the Blue Ribbon Panel report, NCI identified funding opportunity announcements (FOAs) from within its extensive research portfolio that address the goals of the Cancer Moonshot. These opportunities mark the beginning of a growing Cancer Moonshot portfolio which will continue to expand given the authorization of the 21st Century Cures Act to fund the Beau Biden Cancer Moonshot with $1.8 billion over 7 years. While the FOAs listed below highlight research initiatives that align with the efforts of the Cancer Moonshot, they may be supported with existing funds or with the 21st Century Cures funding.

On October 30, 2017 the National Cancer Institute is pleased to announce the release of 17 new Cancer Moonshot funding opportunities. As you know, efforts supported through the Cancer Moonshot aim to accelerate cancer research, making more therapies available to patients and improving the ability to prevent cancer and detect it the earliest stage possible. Learn more about these opportunities here.

Cancer Moonshot - UPDATED Funding Opportunities link